Despite the marked changes of the weights of ovary and liver in both Smad2flox/-; Inha -/- (n = 11) and Smad2flox/-; Inha-/-; Amhr2cre/+ mice (n = 5) compared to WT mice (n = 5; P < 0.01), no significant differences in these parameters were found between the Smad2flox/-; Inha-/-; Amhr2cre/+ mice and the Smad2flox/-; Inha-/- controls at a similar stage of tumor progression (P > 0.05; Figure 3). The gene discussed is INHA; the disease is neoplasm.